Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.

Revenue
−1.68%
EPS
+133.3%
Free cash flow
+88.9%

Quarter to September 2026, against a year earlier

39.72 2.37 −5.63%
Market cap
$2.5B
P/E
37.8×
Fwd P/E
33.3×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 5 Nov
ROE

+8 more TTM periods

26.76% 26.83% 30.14% 31.47%
ROA
13.42% 13.95% 16.48% 16.96%
ROIC
29.83% 28.86% 31.82% 36.76%
Return on Tangible Assets
42.27% 40.43% 41.94% 43.18%
Average Days of Receivables
25.60 28.00 25.88 26.97
Free Cash Flow per Share
1.29 1.11 1.26 0.00
Free Cash Flow
80.71 70.28 79.79 114.06
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026